Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
7,046,893
-
Shares change
-
-412,483
-
Total reported value, excl. options
-
$9,228,368
-
Value change
-
-$579,530
-
Put/Call ratio
-
59%
-
Number of buys
-
14
-
Number of sells
-
18
-
Price
-
$1.31
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q2 2022
As of 30 Jun 2022 GALECTIN THERAPEUTICS INC - COM NEW (GALT) had 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,046,893 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, ADVISOR GROUP HOLDINGS, INC., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Geneos Wealth Management Inc., Atria Wealth Solutions, Inc., MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, Cutter & CO Brokerage, Inc., and Cambridge Investment Research Advisors, Inc..
This table shows 53 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.